MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development

2018 
Background Identification of novel MDM2 or p53 binding proteins may reveal undefined oncogenes, tumor suppressors, signaling pathways and possible treatment targets.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    30
    References
    10
    Citations
    NaN
    KQI
    []